Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
This study aimed to evaluate the efficacy of sitagliptin, a dipeptidyl peptidase IV (DPP-IV) inhibitor, in preventing the deleterious effects of diabetes on the kidney in an animal model of type 2 diabetes mellitus; the Zucker diabetic fatty (ZDF) rat: 20-week-old rats were treated with sitagliptin...
Saved in:
| Main Authors: | Catarina Marques, Cristina Mega, Andreia Gonçalves, Paulo Rodrigues-Santos, Edite Teixeira-Lemos, Frederico Teixeira, Carlos Fontes-Ribeiro, Flávio Reis, Rosa Fernandes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/538737 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
by: Cristina Mega, et al.
Published: (2017-01-01) -
Differential Effects of Acute (Extenuating) and Chronic (Training) Exercise on Inflammation and Oxidative Stress Status in an Animal Model of Type 2 Diabetes Mellitus
by: Edite Teixeira de Lemos, et al.
Published: (2011-01-01) -
Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study
by: Xinfeng Yan, et al.
Published: (2016-01-01) -
Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization
by: Xiaoxia Hu, et al.
Published: (2025-04-01) -
Protective effects of folic acid on ischemia‒reperfusion injury in rat uterus: reduces inflammation damage and apoptotic death
by: Zahid Paksoy, et al.
Published: (2025-07-01)